Theramine
120 ct
Dietary management of pain syndromes and inflammatory conditions
A physician-developed encapsulated medical food intended for people living with chronic pain or inflammation, including low back pain, headaches, or fibromyalgia. Theramine targets the metabolic root of pain through amino acid precursor therapy rather than masking symptoms.
Key differentiator
Best positioned for general chronic pain and inflammation rather than nerve-specific or joint-specific pain
Suggested retail
$54.95
Clinical Details
How It Works
Theramine supplies amino acid precursors that support neurotransmitter synthesis involved in pain modulation and inflammatory response regulation. The formulation targets the metabolic pathways disrupted in chronic pain conditions.
Dosage
2 capsules twice daily; take without food or as directed by physician.
Safety
No significant drug interactions reported. Over 30 million doses safely dispensed. Ingredients are GRAS (Generally Recognized As Safe).
Evidence Summary
Clinical deck plus formulation sheet plus public pageA 28-day double-blind, randomized, multicenter trial of 127 subjects with chronic established back pain showed Theramine achieved statistically significant pain reduction versus naproxen and ibuprofen, with inflammatory marker improvements also reported.
Published Research
Peer-reviewed studies supporting Theramine.
A Double-Blind Controlled Trial of a Single Dose Naproxen and an Amino Acid Medical Food Theramine for the Treatment of Low Back Pain
Featured studyReduction in Pain and Inflammation Associated With Chronic Low Back Pain With the Use of the Medical Food Theramine
Theramine (A Medical Food) Versus Non-Steroidal Anti Inflammatory Agents in Elderly Patients: A Pharmacoeconomic Analysis
Also in Pain Management
Ready to offer Theramine to your patients?
Set up your branded storefront in under 5 minutes. Our AI handles everything else.
See it in action